1. Cohn, J., von Schoen-Angerer, T., Jambert, E., Arreghini, G., Childs, M., 2013. When falsified medicines enter the supply chain: description of an incident in Kenya and lessons learned for rapid response. Journal of Public Health Policy, 34, 22-30. doi:10.1057/jphp.2012.53.
2. Werner V., 2020. 13.B.10 Measures for the protection from counterfeit medicinal products during packaging. GMP Compliance Adviser. GMP-Verlag Peither AG. Available at:https://gmpcadviser.gmp-verlag.de/?action=infounit&value=E1azhFWWtC&anchorlink=Practice_13_Verpackung_13B_023_xml&uilang=de-DE, (Accessed: 26.05.2023).
3. Schwarze S., 2022. 21.H Fight against counterfeit medicines.
4. GMP Advisor. GMP Compliance Adviser. GMP-Verlag Peither AG. Available at: https://gmpcadviser.gmp-verlag.de/?action=infounit&value=peihnbVaIv&anchorlink=Information_Information_00_Preface_ID0EKCBI_177_xml&uilang=de-DE, (Accessed: 26.05.2023).
5. Kleissendorf R., 2019. 13.A.6 Protection against counterfeit medicinal products. GMP Compliance Adviser. GMP-Verlag Peither AG. Available at: URL https://gmpcadviser.gmp-verlag.de/?action=infounit&value=mZfMcD0245&anchorlink=Information_Information_00_Preface_ID0EQZAE_087_xml&uilang=de-DE, (Accessed: 26.05.2023).